:: Library Catalog

Copertina

Salvato in:

Dettagli Bibliografici
Autori principali:	Bruce Strober, Hervé Bachelez, Jeffrey Crowley, Boni E. Elewski, Melinda Gooderham, Alan Menter, Robert Strohal, Michael M. Chen, Tianshuang Wu, Tianyu Zhan, Huzefa Photowala, April Armstrong
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Journal of the European Academy of Dermatology and Venereology
Accesso online:	https://onlinelibrary.wiley.com/doi/10.1111/jdv.19748
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Mission impossible? Caveats in interpreting and comparing long‐term efficacy in biologic studies for moderate‐to‐severe plaque psoriasis
di: Richard G. Langley, et al.
Pubblicazione: (2025)

Pharmacokinetic‐pharmacodynamic modelling of risankizumab using chronic plaque psoriasis real‐world data
di: Charlotte M. Thomas, et al.
Pubblicazione: (2026)

A novel nomogram to predict psoriatic arthritis in patients with plaque psoriasis
di: Minjia Tan, et al.
Pubblicazione: (2024)

Real‐world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate‐to‐severe plaque psoriasis
di: Natalia Rompoti, et al.
Pubblicazione: (2024)

Dysregulation of epigenetic, biological and mitotic age in the context of biologic drug treatment and phototherapy in plaque psoriasis patients
di: Richie Jeremian, et al.
Pubblicazione: (2024)

Effectiveness and safety of risankizumab dose optimization in adult patients with plaque psoriasis: An international multicentre retrospective cohort study
di: A. Bagit, et al.
Pubblicazione: (2024)

Effectiveness of risankizumab for the treatment of psoriatic arthritis: a multicenter, real‐world study
di: Dario Graceffa, et al.
Pubblicazione: (2024)

Effectiveness of ixekizumab for the treatment of moderate‐to‐severe plaque psoriasis with involvement of difficult‐to‐treat areas: A 52‐week multicenter retrospective study
di: Mario Valenti, et al.
Pubblicazione: (2024)

Umbilical psoriasis is not relevant to psoriatic arthritis
di: Maki Takada, et al.
Pubblicazione: (2024)

Systemic exposure and bioavailability of delgocitinib cream in adults with moderate to severe Chronic Hand Eczema
di: Diamant Thaçi, et al.
Pubblicazione: (2025)

Deucravacitinib in plaque psoriasis: Four‐year safety and efficacy results from the Phase 3 POETYK PSO‐1, PSO‐2 and long‐term extension trials
di: April W. Armstrong, et al.
Pubblicazione: (2025)

Disease severity in moderate‐to‐severe plaque psoriasis: Results from the Belgian REDISCOVER study
di: Tom Hillary, et al.
Pubblicazione: (2024)

Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid‐free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's disease
di: Stefan Schreiber, et al.
Pubblicazione: (2024)

Effect of biologic use on the development of psoriatic arthritis: A population‐based study
di: Kathleen L. Miao, et al.
Pubblicazione: (2025)

Deucravacitinib in Japanese patients with plaque, generalized pustular, or erythrodermic psoriasis: Patient‐reported outcomes in the POETYK PSO‐4 study
di: Yayoi Tada, et al.
Pubblicazione: (2024)

Tofacitinib efficacy, patient‐reported outcomes and safety in patients with psoriasis and a medical history of psoriatic arthritis: Pooled analysis of two Phase III studies
di: H. Bachelez, et al.
Pubblicazione: (2024)

Rapid response of nail psoriasis to secukinumab in patients with moderate to severe psoriasis after 12 weeks of treatment with a total of 24 weeks of follow‐up
di: Gang Min Go, et al.
Pubblicazione: (2024)

A comparison of the safety and efficacy of tapinarof and roflumilast topical therapies in the management of mild‐to‐moderate plaque psoriasis
di: Hira Ghani, et al.
Pubblicazione: (2024)

Ixekizumab optimization in moderate‐to‐severe plaque psoriasis in real clinical practice: a retrospective multicenter study
di: Joan Ceravalls, et al.
Pubblicazione: (2026)

Treatment adjustment in biologic therapies for moderate‐to‐severe plaque psoriasis: a German retrospective chart review (TABU)
di: Natalia Kirsten, et al.
Pubblicazione: (2024)

Secular trends in biologic prescribing for psoriasis and psoriatic arthritis, 2014–2024
di: Mahum Mirza, et al.
Pubblicazione: (2025)

Shedding pounds, easing plaques: Weight management in psoriasis
di: Dimitra Koumaki, et al.
Pubblicazione: (2026)

La economía feminista y los conceptos de valor, eficiencia, escasez, egoísmo y competencia: implicaciones para la educación
di: Myra H. Strober
Pubblicazione: (2001)

Applying Active Learning Methods to the Design of Library Instruction for a Freshman Seminar.
di: Dabbour, Katherine Strober
Pubblicazione: (1997)

Real‐world data on the effectiveness of brodalumab in patients with moderate‐to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study)
di: Dimitrios Rigopoulos, et al.
Pubblicazione: (2024)

Anti‐IL‐23 therapy for the treatment of moderate‐to‐severe inverse psoriasis: A 52‐week multicenter study
di: Joan Ceravalls, et al.
Pubblicazione: (2024)

Risk of peripheral neuropathy in patients with psoriasis and psoriatic arthritis. A prospective cohort study
di: Pietro E. Doneddu, et al.
Pubblicazione: (2024)

RETRACTED: Mendelian randomization analysis of psoriasis and psoriatic arthritis associated with risks of ulcerative colitis
di: Jing Pan, et al.
Pubblicazione: (2024)

Biologic therapies and psoriatic arthritis risk in psoriasis: A systematic review and meta‐analysis
di: Li Yang, et al.
Pubblicazione: (2026)

Successful treatment with granulocyte and monocyte adsorption apheresis for plaque‐type skin lesions in patients with psoriatic arthritis
di: Mariko Seishima, et al.
Pubblicazione: (2024)

Addressing Unmet Needs in Prurigo Nodularis: Expert Canadian Dermatology Perspectives
di: Vimal H. Prajapati, et al.
Pubblicazione: (2026)

Helicobacter pylori infection in psoriatic patients and its relation to psoriasis severity: Cross Sectional Study
di: Soheir Abdel‐Hamid, et al.
Pubblicazione: (2024)

In Response to Now You See It, Now You Don't: Laryngoscopy Findings of Paradoxical Vocal Fold Motion
di: William Strober, et al.
Pubblicazione: (2025)

Bimekizumab efficacy and safety in Korean patients with moderate to severe plaque psoriasis: A phase 3, randomized, placebo‐controlled, double‐blinded study
di: Sang Woong Youn, et al.
Pubblicazione: (2024)

Modeling pulsed dye laser treatment of psoriatic plaques by combining numerical methods and image‐derived lesion morphologies
di: Leah S. Wilk, et al.
Pubblicazione: (2024)

Transcriptomic meta‐analysis identifies core molecular pathways in plaque psoriasis
di: Teresa Torres‐Moral, et al.
Pubblicazione: (2026)

Reply to ‘Delayed absorption and systemic variability of topical delgocitinib in Chronic Hand Eczema’
di: Diamant Thaçi, et al.
Pubblicazione: (2025)

Depression screening for psoriasis in the United States: A population‐based study
di: Margaret Y. Huang, et al.
Pubblicazione: (2024)

Efficacy and safety of topical rosuvastatin & melatonin vs. placebo in patients with mild to moderate plaque psoriasis: A preliminary randomized double‐blinded clinical trial
di: Farhad Mohammadi, et al.
Pubblicazione: (2024)

Biologic treatment sequences in moderate‐to‐severe psoriasis
di: Samantha Ting, et al.
Pubblicazione: (2024)